1. Home
  2. MLTX vs WHD Comparison

MLTX vs WHD Comparison

Compare MLTX & WHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • WHD
  • Stock Information
  • Founded
  • MLTX 2021
  • WHD 2011
  • Country
  • MLTX Switzerland
  • WHD United States
  • Employees
  • MLTX N/A
  • WHD N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • WHD Metal Fabrications
  • Sector
  • MLTX Health Care
  • WHD Industrials
  • Exchange
  • MLTX Nasdaq
  • WHD Nasdaq
  • Market Cap
  • MLTX 2.3B
  • WHD 2.7B
  • IPO Year
  • MLTX N/A
  • WHD 2018
  • Fundamental
  • Price
  • MLTX $38.60
  • WHD $42.05
  • Analyst Decision
  • MLTX Strong Buy
  • WHD Hold
  • Analyst Count
  • MLTX 8
  • WHD 6
  • Target Price
  • MLTX $80.50
  • WHD $52.33
  • AVG Volume (30 Days)
  • MLTX 434.1K
  • WHD 927.4K
  • Earning Date
  • MLTX 05-20-2025
  • WHD 04-30-2025
  • Dividend Yield
  • MLTX N/A
  • WHD 1.24%
  • EPS Growth
  • MLTX N/A
  • WHD 11.86
  • EPS
  • MLTX N/A
  • WHD 2.83
  • Revenue
  • MLTX N/A
  • WHD $1,136,010,000.00
  • Revenue This Year
  • MLTX $103.42
  • WHD $1.34
  • Revenue Next Year
  • MLTX N/A
  • WHD $5.85
  • P/E Ratio
  • MLTX N/A
  • WHD $14.87
  • Revenue Growth
  • MLTX N/A
  • WHD N/A
  • 52 Week Low
  • MLTX $31.42
  • WHD $33.80
  • 52 Week High
  • MLTX $58.26
  • WHD $70.01
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 53.31
  • WHD 55.70
  • Support Level
  • MLTX $36.75
  • WHD $39.38
  • Resistance Level
  • MLTX $42.90
  • WHD $40.83
  • Average True Range (ATR)
  • MLTX 2.06
  • WHD 1.43
  • MACD
  • MLTX 0.03
  • WHD 0.78
  • Stochastic Oscillator
  • MLTX 58.04
  • WHD 87.01

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

Share on Social Networks: